Adalvo and STADA extend their strategic partnership

Share This Post

STADA has extended its strategic partnership with Adalvo

Strategic partnership in Europe extended to cover five additional molecules in therapeutic categories including oncology and diabetes

Working closely as a trusted partner with Adalvo is central to STADA’s commitment to caring for people’s health by supplying specialty, generic and consumer healthcare medicines”

— Yann Brun, STADA

BAD VILBEL, HESSE, GERMANY, January 11, 2023 /EINPresswire.com/ — Adalvo and STADA extend their strategic partnership

• Strategic partnership in Europe extended to cover five additional molecules in therapeutic categories including oncology and diabetes

• Adalvo CEO Anil Okay: “These new agreements demonstrate the significance of the strategic partnership we have built with STADA, in the last couple of years. We take pride in making a difference in people’s lives, by bringing high quality medicines to the market, together with our partner.”

• STADA’s Head of Global Development, Portfolio, Regulatory and Business Development/Licensing, Yann Brun: “Working closely as a trusted partner with Adalvo is central to STADA’s commitment to caring for people’s health by supplying specialty, generic and consumer healthcare medicines.”

Adalvo and STADA have extended their strategic partnership by recently signing licensing deals for five additional molecules. The agreements give STADA commercial rights to the molecules within Europe.

Among the active ingredients covered by recently-signed deals are several molecules for oncology and diabetes, therapeutic categories that are forecast to be among the largest and fastest-growing within the global pharma sector over the coming years. The extension to the long-standing strategic partnership between Adalvo and STADA involves a variety of delivery forms, including difficult-to-make formulations.

The two partners expect the deal to strengthen their position in the generic and value-added medicines sectors, providing patients and their caregivers with high-quality and affordable treatment options.

Anil Okay, CEO at Adalvo, comments: “These new agreements demonstrate the significance of the strategic partnership we have built with STADA, in the last couple of years. We take pride in making a difference in people’s lives, by bringing high-quality medicines to the market, together with our partner.”

Yann Brun, STADA’s Head of Global Development, Portfolio, Regulatory and Business Development/Licensing, states: “Working closely as a trusted partner with Adalvo is central to STADA’s commitment to caring for people’s health by supplying specialty, generic and consumer healthcare medicines, including in essential therapeutic categories such as oncology and diabetes.”

About Adalvo

Adalvo is a global pharmaceutical company, and one of the leading B2B pharmaceutical companies in Europe, with commercial partnerships in more than 100 countries and for over 110 commercial partners globally. The company’s declared purpose is to make a difference for patients all over the world, driven by our smart collaboration network and commitment to delivering highest quality differentiated products and services to our partners.

With headquarters in Malta, the company has additional offices in more than 16 countries. At Adalvo, we know that our partners like to be bigger, better, and smarter in the dynamic pharmaceutical sector. That’s why our approach is unique, customized to our partners, and is designed to challenge the status quo: together, this helps our partners achieve their business goals.

We take pride in our ability to help its partners reach their goals – be those increasing revenues or pushing into new markets. While partners are a high priority, Adalvo is also committed to its purpose and mission to accelerate the growth and development of employees and local communities. Adalvo tirelessly strives for excellence in all of its endeavors, driven by a deep-rooted passion to making a difference for partners. The company’s purpose driven culture is committed to improving the lives of patients around the world. Our dynamic leadership team brings significant experience and industry know-how to Adalvo, which has helped to establish the company as a reliable global partner.

About STADA Arzneimittel AG

STADA Arzneimittel AG is headquartered in Bad Vilbel, Germany. The company focuses on a three-pillar strategy consisting of generics, specialty pharma and non-prescription consumer healthcare products. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. In financial year 2021, STADA achieved group sales of EUR 3,249.5 million and reported earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 776.5 million. As of 31 December 2021, STADA employed 12,520 people worldwide.

Adalvo Corporate Communication:

Gabi Cassar

Tel: +356 7920 2846

E-mail: gabrielle.cassar@adalvo.com

STADA information for journalists:

STADA Arzneimittel AG – Media Relations

Stadastrasse 2-18

61118 Bad Vilbel – Germany

Phone: +49 (0) 6101 603-165

E-Mail: press@stada.de

Or visit us on the Internet at www.stada.com/press

Follow STADA on LinkedIn

STADA information for capital market participants:

STADA Arzneimittel AG – Investor & Creditor Relations

Stadastrasse 2-18

61118 Bad Vilbel – Germany

Phone: +49 (0) 6101 603-4689

Fax: +49 (0) 6101 603-215

E-mail: ir@stada.de

Or visit us on the Internet at www.stada.com/investor-relations

STADA Media Relations
STADA
+49 6101 603165
email us here



Article originally published at https://www.einpresswire.com/article/610687948/adalvo-and-stada-extend-their-strategic-partnership

Related Posts

FTC and DOJ File Statement of Interest in Hotel Room Algorithmic Price-Fixing Case

The Federal Trade Commission joined by the Justice Department’s...

FTC Releases 2023 Privacy and Data Security Update

The Federal Trade Commission released its Privacy and Data...

RedeemTV Announces New Documentary: ‘The Shroud Face to Face’

RedeemTV Announces New Documentary: ‘The Shroud Face to Face’
Company Logo

RedeemTV ? Streaming Goodness

Vision Video’s streaming platform RedeemTV is set to unveil the highly anticipated documentary The Shroud Face to Face on March 28, 2024.

The Shroud Face to Face, produced by The Nexus Institute and The Shroud LLC, is a captivating documentary that unravels the enigma of the Shroud of Turin. With cutting-edge technology and expert insights, the film provides a face-to-face encounter with this iconic relic, inviting audiences to delve into its history, authenticity, and the profound questions it raises.

This visually stunning film, based on the book The Shroud Face to Face by acclaimed author and filmmaker Robert Orlando, offers an immersive exploration of the centuries-old mystery surrounding the Shroud of Turin and has been endorsed with high praise.

"This is a compelling and convincing account of the single most fascinating relic in the Christian world. This is for anyone seeking to understand the significance and history of the Shroud of Turin.” — Bishop Robert Barron, founder of Word on Fire

'The Shroud Face to Face'

Watch Trailer: https://watch.redeemtv.com/trailer/the-shroud-trailer

RedeemTV is a FREE, donor-supported, Christian streaming platform with over 250,000 subscribers. Streaming more than 5,000 videos, it provides family-friendly content while continuing to spread the message of Jesus.

Vision Video is a leading DVD and film distributor, committed to bringing impactful and compelling stories to audiences worldwide. With a focus on cinematic excellence, Vision Video partners with filmmakers to showcase thought-provoking narratives that inspire and captivate.

The Nexus Media focuses on TV, motion pictures, books, and screenplays, along with award- winning documentaries and shorts. Our team has years of experience in media storytelling and developing well-crafted engaging content. We invite you to view some of our past projects, The Divine Plan and Silence Patton, and participate in our new initiatives.

Stream FREE on RedeemTV: https://redeemtv.com.

Find us on Facebook at https://www.facebook.com/RedeemTV.

Follow us on Instagram at https://www.instagram.com/redeemtv1.

Contact Information:
Danielle Tumminelli
Marketing & VOD Distribution Manager
danielle@visionvideo.com
484-750-2485


Original Source: RedeemTV Announces New Documentary: 'The Shroud Face to Face'
green agriculture project
- Part of VUGA Media group -best seo company